Today, the U.S. Food and Drug Administration (FDA) requested that SEI Pharmaceuticals of Miami, Florida recall all Xiadafil VIP Tabs sold in eight tablet bottles (Lot # 6K029) or blister cards of two tablets (Lot # 6K029-SEI). Florida officials issued a “stop sale” action at SEI’s Miami distribution facility on May 13 that required SEI to hold—intact—violative Xiadafil VIP Tabs found on-hand at the facility.
The Xiadafil VIP Tabs contain a potentially harmful, undeclared ingredient found in the prescription drug Viagra that may dangerously affect a person’s blood pressure as well as cause other life-threatening side effects. The lots of Xiadafil VIP Tabs containing the potentially dangerous ingredient, bear an expiration date of September 2009 (09/09). Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and claim to treat erectile dysfunction (ED). (more…)

